How long will the 'medical food' window of opportunity remain open?

Journal of Nutraceuticals, Functional and Medical Foods

Volumn 1, Issue 3, 1998, Pages 45-57

  Aarts, Thomas D ^a,b  

^a Nutrition Business International   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Market size; Medical foods; Regulatory and marketing categories; Regulatory impact

Indexed keywords

NEOCATE; NITEBITE; UNCLASSIFIED DRUG; ZBAR;

CONSUMER; DIABETES CONTROL; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; FOOD; FOOD AND DRUG ADMINISTRATION; FOOD INDUSTRY; HUMAN; HYPERTENSION; INFANT NUTRITION; MARKETING; NUTRITION; SALT INTAKE; SHORT SURVEY;

EID: 0031412662     PISSN: 10894179     EISSN: None     Source Type: Journal    
DOI: 10.1300/j133v01n03_04     Document Type: Short Survey

References (4)

1. Peter Barton Hutt, Regulatory Update, presented at Nutracon '97, Las Vegas, NV, July 17-18, 1997.
2. Stephen H. McNamara, FDA Regulation of "Medical Foods" - An Industry Perspective, presented at the conference, "How to Develop, Make Claims On & Market Medical Foods," New York, NY, November 20-21, 1996.
3. Anon. FMI Shopping for Health Annual Surveys. Chicago: 1990-1995.
4. Nonprescription Drug Manufacturer's Association Statistics, May, 1997. Washington, DC.